Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results

Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 6c, Revenues Beat

November 6, 2019 4:43 PM EST

Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of $0.13, $0.06 better than the analyst estimate of $0.07. Revenue for the quarter came in at $59.49 million versus the consensus estimate of $58.32 million.

"These results affirm Vanda's corporate strategy, and continue to demonstrate our ability to grow... More